https://www.thebodypro.com/author/tim-horn

Latest by Tim Horn

Better Late Than Never: Efavirenz Dose Optimization Img

Better Late Than Never: Efavirenz Dose Optimization

Research is emerging that Sustiva -- one of the drugs in Atripla, and a major culprit of neurological side effects among people who take it -- doesn't actually need to be taken at its commonly prescribed dose.

Promo Image
News Analysis

Preparing for Generics: The Push for Affordable HIV Treatment Doesn't End With Patent Expirations

The United States is on course for some much-needed economic relief from the crippling cost of HIV treatment, with the anticipated arrival of generic versions of guidelines-preferred antiretrovirals. However, much preparation is required to maximize...

Promo Image

Treatment Interruptions: SMART or Stupid?

Ten years ago, when HAART (highly active antiretroviral therapy) made its debut, the theory behind using a combination of HIV drugs seemed easy enough to understand. Preliminary data suggested that HIV could be cured -- "eradicated," as experts were ...

Promo Image
Lipodystrophy/Body Fat

Inching Forward: An Update on Lipodystrophy and Possible Treatments

What Causes It? Can Lipodystrophy Be Prevented? How Can It Be Treated? What Are Facial Fillers? Covering the Cost of Facial Fillers Where Do We Go From Here?

More than just a tongue-twister, the term "lipodystrophy" can be broken down to...

Promo Image

The Food and Drug Administration: The Process of Approval

For every dollar the typical American spends, approximately 25 cents goes to products that are regulated by the U.S. Food and Drug Administration (FDA). We're talking about everything from food, to drugs, to radiation-emitting products like cell phon...

Promo Image

Personal Perspective: Ode to the World Wide Web

I confess. I am an unabashed World Wide Web junkie. I shudder at the thought of how much time I have spent over the years gawking at Web sites dedicated to sex, automotive design and repair, sex, online auctions and shopping (I will never set foot in...

Promo Image

Opportunistic Infections: They're Still Here

Bacterial Infections Viral Infections Fungal Infections Protozoal Infections The Bottom Line

When I first got involved in HIV/AIDS treatment education and advocacy work about ten years ago, more than 40,000 people were dying of AIDS every ...

Promo Image

The Other Hepatitis: The ABCs of HBV

Hepatitis B and Hepatitis C: Similarities and Differences Acute Hepatitis B Chronic Hepatitis B The HIV Question Treating Chronic Hepatitis B The Hope of Combination Therapy Important Hepatitis B Blood Tests

Hepatitis B has been nothin...

Promo Image
Lipodystrophy/Body Fat

Fibrates and Statins and Glitazones (Oh My!)

It's hard to say what's more frustrating -- the fact that we still don't know what causes lipodystrophy, or the fact that we still don't know how best to treat it. Even if researchers eventually conclude that specific antiretrovirals are responsible ...

Promo Image

Seeing Double: A Tale of Dual Protease Inhibitors

It's hard to believe, but it has been more than five years since the protease inhibitors (PIs) made their therapeutic debut and forever changed our approach to managing HIV. Perhaps the most impressive aspect of this milestone is that researchers and...